OrbiMed Advisors now holds 6%+ .. Opaleye 25+, and Insiders 10%+… other funds total 20%+ aggregated…float is locked up, will go parabolic if ph1/B announced in Q2.. I’ve been buying under $3.5 for weeks now..You still playing ticker??
Same here, holding and slowly adding for a play in 2022! With Cash&equiv of $150mm+, they have runway into 2023 or so( intrinsic value of ~ $10 a share) .. we just got to hope Mgmt doesn’t use for personal piggy bank! In addition, more Virtual Conf’s: Oppenheimer Rare & Orphan Disease Summit on Friday, May 21, 2021 at 11:35am ET..Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 1:30pm ET
This one is beat up. Expectations on earnings pushed back. Buy and hold at below $11.00/share. April 26th - Oppenheimer adjusted PT from $43 to $32, but still maintains an Outperform Rating. Could be a triple from today's prices. I am holding my nose and buying. Also, not much available at this price, so the majority of shareholders are holding./ok2